The long battle in the American courts over Myriad Genetics’ patents of BRCA1 and BRCA2, the primary diagnostic genes for hereditary breast and ovarian cancer
On November 30, 2012 the US Supreme Court agreed to hear the appeal in the case of Association for Molecular Pathology v Myriad Genetics Inc.
Obesity and chronic diseases, like diabetes and heart disease, are on the rise. To solve this crisis, we seem to be searching for the next
Japanese scientists report they have, for the first time, grown mammalian eggs from stem cells and that these artificially created eggs were used to produce healthy offsprings. This
One year after President Obama signed America’s patent reform bill into law, the U.S. Patent and Trademarks Office (USPTO) has introduced a new way for
The United States Court of Appeals for the Federal Circuit, in the case Association for Molecular Pathology (AMP) and ACLU v. USPTO and Myriad Genetics
